JP2014510788A5 - - Google Patents

Download PDF

Info

Publication number
JP2014510788A5
JP2014510788A5 JP2014505231A JP2014505231A JP2014510788A5 JP 2014510788 A5 JP2014510788 A5 JP 2014510788A5 JP 2014505231 A JP2014505231 A JP 2014505231A JP 2014505231 A JP2014505231 A JP 2014505231A JP 2014510788 A5 JP2014510788 A5 JP 2014510788A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
unsaturated
ocf
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014505231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014510788A (ja
JP6317669B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/032994 external-priority patent/WO2012173689A2/en
Publication of JP2014510788A publication Critical patent/JP2014510788A/ja
Publication of JP2014510788A5 publication Critical patent/JP2014510788A5/ja
Application granted granted Critical
Publication of JP6317669B2 publication Critical patent/JP6317669B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014505231A 2011-04-15 2012-04-11 抗菌化合物ならびにそれを作製および使用する方法 Active JP6317669B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161476138P 2011-04-15 2011-04-15
US61/476,138 2011-04-15
US201161535118P 2011-09-15 2011-09-15
US61/535,118 2011-09-15
US201261610363P 2012-03-13 2012-03-13
US61/610,363 2012-03-13
PCT/US2012/032994 WO2012173689A2 (en) 2011-04-15 2012-04-11 Antimicrobial compounds and methods of making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018068456A Division JP2018115206A (ja) 2011-04-15 2018-03-30 抗菌化合物ならびにそれを作製および使用する方法

Publications (3)

Publication Number Publication Date
JP2014510788A JP2014510788A (ja) 2014-05-01
JP2014510788A5 true JP2014510788A5 (cg-RX-API-DMAC10.html) 2015-05-28
JP6317669B2 JP6317669B2 (ja) 2018-04-25

Family

ID=47357660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014505231A Active JP6317669B2 (ja) 2011-04-15 2012-04-11 抗菌化合物ならびにそれを作製および使用する方法
JP2018068456A Pending JP2018115206A (ja) 2011-04-15 2018-03-30 抗菌化合物ならびにそれを作製および使用する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018068456A Pending JP2018115206A (ja) 2011-04-15 2018-03-30 抗菌化合物ならびにそれを作製および使用する方法

Country Status (21)

Country Link
US (2) US9221827B2 (cg-RX-API-DMAC10.html)
EP (2) EP3404028A1 (cg-RX-API-DMAC10.html)
JP (2) JP6317669B2 (cg-RX-API-DMAC10.html)
KR (1) KR20140065378A (cg-RX-API-DMAC10.html)
CN (2) CN103958514B (cg-RX-API-DMAC10.html)
AR (1) AR088781A1 (cg-RX-API-DMAC10.html)
AU (3) AU2012271228B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013026410A2 (cg-RX-API-DMAC10.html)
CA (1) CA2833169A1 (cg-RX-API-DMAC10.html)
DK (1) DK2697229T3 (cg-RX-API-DMAC10.html)
EA (1) EA201391536A1 (cg-RX-API-DMAC10.html)
ES (1) ES2665988T3 (cg-RX-API-DMAC10.html)
HU (1) HUE036755T2 (cg-RX-API-DMAC10.html)
IL (1) IL228845A0 (cg-RX-API-DMAC10.html)
MX (1) MX357903B (cg-RX-API-DMAC10.html)
MY (1) MY173518A (cg-RX-API-DMAC10.html)
PH (1) PH12013502135A1 (cg-RX-API-DMAC10.html)
PT (1) PT2697229T (cg-RX-API-DMAC10.html)
SG (2) SG194489A1 (cg-RX-API-DMAC10.html)
TW (2) TW201843154A (cg-RX-API-DMAC10.html)
WO (1) WO2012173689A2 (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0739738Y2 (ja) 1989-10-03 1995-09-13 三菱農機株式会社 機体転倒防止装置
JP6274723B2 (ja) 2009-10-16 2018-02-07 メリンタ セラピューティクス,インコーポレイテッド 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
EP3406613A1 (en) 2009-10-16 2018-11-28 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
JP2013508299A (ja) 2009-10-16 2013-03-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
EP3404028A1 (en) 2011-04-15 2018-11-21 Melinta Therapeutics, Inc. Methods of making antimicrobial compounds
US9346802B2 (en) 2013-03-15 2016-05-24 Epizyme, Inc. CARM1 inhibitors and uses thereof
EP2970266B1 (en) 2013-03-15 2018-01-31 Epizyme, Inc. 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
WO2014144169A1 (en) 2013-03-15 2014-09-18 Epizyme, Inc. Carm1 inhibitors and uses thereof
MX2016002975A (es) * 2013-09-09 2016-10-21 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
US9937183B2 (en) 2013-09-09 2018-04-10 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
US20180141897A1 (en) 2014-12-08 2018-05-24 The Research Foundation For The State University Of New York Anti-fungals targeting the synthesis of fungal shingolipids
WO2016145417A1 (en) * 2015-03-11 2016-09-15 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CN105669519B (zh) * 2016-01-04 2018-01-05 北方民族大学 吲哚类化合物、制备方法及其作为抗耐药菌药物的应用
EP3452478A1 (en) 2016-05-06 2019-03-13 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same
US10934295B2 (en) * 2016-05-06 2021-03-02 BioVersys AG Antimicrobials and methods of making and using same
US11098047B2 (en) * 2016-05-06 2021-08-24 BioVersys AG Antimicrobials and methods of making and using same
EP3638649A4 (en) 2017-06-16 2021-03-17 The Research Foundation for The State University of New York FUNGUSKID AGENTS AGAINST THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
EP3642205A1 (en) 2017-06-19 2020-04-29 Erin M. Duffy Antimicrobials and methods of making and using same
WO2019164880A1 (en) * 2018-02-21 2019-08-29 Duffy Erin M Antimicrobials and methods of making and using same
WO2019234508A1 (en) 2018-06-06 2019-12-12 BioVersys AG Biodefense agents
US20210253589A1 (en) 2018-06-06 2021-08-19 BioVersys AG Aminomethylamidine and methylamidine antimicrobial compounds
WO2020115547A2 (en) * 2018-12-07 2020-06-11 BioVersys AG Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds
CA3126815A1 (en) 2019-01-16 2020-07-23 Curza Global, Llc Antimicrobial compounds and methods
JP2022518230A (ja) 2019-01-16 2022-03-14 カーザ グローバル, エルエルシー 抗菌化合物及び方法
CA3158103A1 (en) * 2019-11-13 2021-05-20 Curza Global, Llc Antimicrobial compounds and methods
CN111254091B (zh) * 2020-01-20 2022-04-19 浙江工业大学 一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JP2873340B2 (ja) 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質tan―1057,その製造法および用途
US5958930A (en) 1991-04-08 1999-09-28 Duquesne University Of The Holy Ghost Pyrrolo pyrimidine and furo pyrimidine derivatives
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
GB9708611D0 (en) 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
EP1003727A1 (en) 1997-08-07 2000-05-31 Research Corporation Technologies Antibiotic for methicillin resistant bacteria
DE19838998A1 (de) 1998-08-27 2000-03-09 Bayer Ag Neue Naturstoffderivate
EP1113008A1 (en) 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
KR100358083B1 (ko) * 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
DE10061538A1 (de) 2000-12-11 2002-06-20 Bayer Ag Ureido-Dihydropyrimidinone
DE10061542A1 (de) 2000-12-11 2002-06-13 Bayer Ag Alkanoylamino-pyrimidine
DE10061541A1 (de) 2000-12-11 2002-06-20 Bayer Ag Arylamino-Dihydropyrimidinone
DE10061537A1 (de) 2000-12-11 2002-06-20 Bayer Ag beta-Alanin-Derivate
US6900215B2 (en) 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
DE10133277A1 (de) 2001-07-09 2003-01-23 Bayer Ag ß-Alanin-Derivate
DE10141271A1 (de) 2001-08-23 2003-03-06 Bayer Ag Neue Tetrahydro-1,3,5-triazin-2-on-Derivate und ihre Verwendung
DE10208256A1 (de) 2002-02-26 2003-09-04 Bayer Ag Piperidinouracile
WO2004080466A1 (en) 2003-03-07 2004-09-23 Ribapharm Inc. Cytidine analogs and methods of use
CN1871240B (zh) 2003-08-26 2012-11-07 帝人制药株式会社 吡咯并嘧啶酮衍生物
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
KR20080003599A (ko) * 2006-07-03 2008-01-08 에스케이케미칼주식회사 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법
CA2666696C (en) * 2006-07-03 2013-01-15 Sk Chemicals Co., Ltd. Salts of pyrrolopyrimidinone derivatives and process for preparing the same
WO2008082440A2 (en) 2006-08-25 2008-07-10 Emory University Fluorescent nucleoside analogues
ES2362805T3 (es) * 2006-09-07 2011-07-13 Industrial Research Limited Inhibidores aminoacíclicos de nucleósido fosforilasas e hidrolasas.
JP2008222557A (ja) 2007-03-08 2008-09-25 Kotobuki Seiyaku Kk ピロロ[3,2−d]ピリミジン誘導体及びこれを有効成分とする医薬組成物
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
KR20090098710A (ko) 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
UY32395A (es) 2009-01-27 2010-08-31 Takeda Pharmaceutical Compuesto con anillo fusionado y su uso
US8975389B2 (en) * 2009-03-02 2015-03-10 Alnylam Pharmaceuticals, Inc. Nucleic acid chemical modifications
US20120263646A1 (en) 2009-10-15 2012-10-18 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
NZ623384A (en) * 2009-10-16 2016-06-24 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
EP3406613A1 (en) 2009-10-16 2018-11-28 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
EP3404028A1 (en) 2011-04-15 2018-11-21 Melinta Therapeutics, Inc. Methods of making antimicrobial compounds

Similar Documents

Publication Publication Date Title
JP2013508297A5 (cg-RX-API-DMAC10.html)
JP2013508299A5 (cg-RX-API-DMAC10.html)
JP2013508298A5 (cg-RX-API-DMAC10.html)
US20250257075A1 (en) Macrocyclic inhibitors of kras for the treatment of cancer
US20250268894A1 (en) Macrocycle compounds for the treatment of cancer
JP2016121171A5 (cg-RX-API-DMAC10.html)
CA2433197A1 (en) Gyrase inhibitors and uses thereof
ES2542431T3 (es) Monobactamas
ES2305732T3 (es) Derivados de hidroisoxazol sustituidos con hidroximetilo utiles como agentes antibioticos.
JP2022515197A5 (cg-RX-API-DMAC10.html)
IL165715A (en) 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EP2814483A2 (en) Methods of treating bacterial infections
CA2747965C (en) Novel antibacterial agents for the treatment of gram positive infections
AU2015231234B2 (en) Antifungal compound process
EP2762480A1 (en) Oxazolidinone antibiotics containing fused ring
JP2007514782A5 (cg-RX-API-DMAC10.html)
JP2017514790A (ja) 抗真菌化合物の調製方法
WO2018152548A4 (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
JP2007500707A5 (cg-RX-API-DMAC10.html)
KR102237887B1 (ko) 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
CN107400126A (zh) 新型噁唑烷酮类化合物及其制备方法和在医学上的应用
EP1793823B1 (en) Phosphate containing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
JP2008543964A5 (cg-RX-API-DMAC10.html)
Kim et al. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
WO2025147685A1 (en) Triterpenoid antifungals for use in the treatment of mucormycosis